Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
  • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
  • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
  • C07D209/04—Indoles; Hydrogenated indoles
  • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
  • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
  • A61K31/404—Indoles, e.g. pindolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
  • A61P25/16—Anti-Parkinson drugs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Veterinary Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Biomedical Technology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Epidemiology (AREA)
• Psychiatry (AREA)
• Psychology (AREA)
• Hospice & Palliative Care (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Indole Compounds (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=54199404

Family Applications (1)

Country Status (28)

Families Citing this family (12)

Family Cites Families (4)

• 2014
  • 2014-02-20 NZ NZ719671A patent/NZ719671A/en unknown
  • 2014-02-20 AU AU2014358682A patent/AU2014358682B2/en active Active
  • 2014-02-20 CN CN201480065601.9A patent/CN105814020B/zh active Active
  • 2014-02-20 LT LTEP14725245.6T patent/LT3077375T/lt unknown
  • 2014-02-20 BR BR112016010788-8A patent/BR112016010788B1/pt active IP Right Grant
  • 2014-02-20 HU HUE14725245A patent/HUE036008T2/hu unknown
  • 2014-02-20 JP JP2016535680A patent/JP6151453B2/ja active Active
  • 2014-02-20 MX MX2016006629A patent/MX364930B/es active IP Right Grant
  • 2014-02-20 PL PL14725245T patent/PL3077375T3/pl unknown
  • 2014-02-20 CA CA2929309A patent/CA2929309C/en active Active
  • 2014-02-20 SM SM20170408T patent/SMT201700408T1/it unknown
  • 2014-02-20 HR HRP20171245TT patent/HRP20171245T1/hr unknown
  • 2014-02-20 DK DK14725245.6T patent/DK3077375T3/en active
  • 2014-02-20 RS RS20170853A patent/RS56323B1/sr unknown
  • 2014-02-20 US US15/100,489 patent/US9540321B2/en active Active
  • 2014-02-20 EP EP14725245.6A patent/EP3077375B1/en active Active
  • 2014-02-20 EA EA201691161A patent/EA028038B1/ru unknown
  • 2014-02-20 PT PT147252456T patent/PT3077375T/pt unknown
  • 2014-02-20 AP AP2016009224A patent/AP2016009224A0/en unknown
  • 2014-02-20 SI SI201430348T patent/SI3077375T1/sl unknown
  • 2014-02-20 WO PCT/IN2014/000109 patent/WO2015083179A1/en not_active Ceased
  • 2014-02-20 IN IN5537CH2013 patent/IN2013CH05537A/en unknown
  • 2014-02-20 ES ES14725245.6T patent/ES2638856T3/es active Active
  • 2014-02-20 ME MEP-2017-193A patent/ME02843B/me unknown
  • 2014-02-20 KR KR1020167013965A patent/KR101808792B1/ko active Active
• 2016
  • 2016-05-03 ZA ZA2016/02954A patent/ZA201602954B/en unknown
  • 2016-05-11 IL IL245619A patent/IL245619B/en active IP Right Grant
• 2017
  • 2017-08-28 CY CY20171100904T patent/CY1119298T1/el unknown

Also Published As

Similar Documents